Vyant Bio, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2012 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vyant Bio, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2012 to Q4 2022.
  • Vyant Bio, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2022 was 5.87M shares, a 29.7% increase year-over-year.
  • Vyant Bio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 5.87M shares, a 29.7% increase from 2021.
  • Vyant Bio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 4.53M shares.
  • Vyant Bio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2016 was 15.9M shares, a 54% increase from 2015.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 5.87M +1.34M +29.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 5.88M +85.4K +1.47% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 29.4M +427K +1.47% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 29M +25.8M +811% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 4.53M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 5.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 29M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 3.18M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2018 27.4M +5.79M +26.8% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-19
Q2 2018 27M +7.35M +37.3% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q3 2017 21.6M +5.06M +30.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 19.7M +5.16M +35.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 18.9M +5.36M +39.5% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-12
Q4 2016 15.9M +5.56M +54% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-23
Q3 2016 16.5M +6.79M +69.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 14.5M +4.82M +49.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 13.5M +3.84M +39.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 10.3M +849K +8.99% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 9.73M +150K +1.57% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 9.71M +412K +4.43% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-10
Q1 2015 9.7M +427K +4.61% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 9.45M +4.78M +103% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 9.58M +4.52M +89.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 9.3M +5.32M +133% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 9.28M +7.93M +587% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 4.67M +3.32M +248% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 5.06M +3.71M +276% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 3.99M +2.64M +196% Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-09-23
Q1 2013 1.35M +20.7K +1.55% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 1.34M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 1.35M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 1.35M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 1.33M Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-06-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.